Text Size

Erectile Dysfunction and Diabetes Mellitus

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00134329
First received: August 23, 2005
Last updated: December 19, 2007
Last verified: December 2007
History of Changes
  Purpose

This study consists of filling out a questionnaire on possible erectile dysfunction.


Condition Intervention
Diabetes Mellitus
Erectile Dysfunction
 Procedure: Filling out a questionnaire on the possible occurrence of erectile dysfunction

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Erectile Dysfunction and Diabetes Mellitus

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Documentation of the prevalence of erectile dysfunction in the diabetic convention
  • Increase the awareness of diabetologist for erectile dysfunction
  • Relation of erectile dysfunction with metabolic parameters
  • Relation of erectile dysfunction with sex steroids

Secondary Outcome Measures:
  • Adjustment of the systematic follow-up of diabetic complications.
  • Optimalisation of the healthcare for diabetic patients, so that the quality of life for male diabetic patients can be improved

Estimated Enrollment: 300
Study Start Date: May 2005
Study Completion Date: March 2007
Detailed Description:

Male diabetic patients who attend a diabetic routine year program visit will be asked to give their voluntary permission to fill out a questionnaire on possible erectile dysfunction.

The questionnaire consists of two parts: Part 1 is the IIEF (International Index of Erectile Function) questionnaire and Part 2 is an additional questionnaire. The included patients have to fill out these questionnaires two times; once at the beginning at a diabetic year program visit and a second time one year later at the next diabetic year program consultation.

The patients will also be asked to give their permission for using their results of the routine diabetic year program for scientific research.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male diabetic patients
  • Age older than 18 years

Exclusion Criteria:

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00134329

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Guy T'Sjoen, MD University Hospital, Ghent
  More Information

Additional Information:
Website University Hospital Ghent  This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier: NCT00134329     History of Changes
Other Study ID Numbers: 2005/096
Study First Received: August 23, 2005
Last Updated: December 19, 2007
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus
Erectile Dysfunction
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
 Sexual Dysfunction, Physiological
Genital Diseases, Male
Sexual Dysfunctions, Psychological
Sexual and Gender Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013